IBS and IBD are two different conditions that are easy to mix up, and the difference matters. IBS, irritable bowel syndrome, is a disorder of how the gut and brain interact. It causes real and sometimes severe symptoms, but it does not inflame or damage the bowel. IBD, inflammatory bowel disease, is the collective name for Crohn's disease and ulcerative colitis, conditions in which the immune system attacks the gut and causes visible inflammation and ulcers. IBD needs specialist treatment, and finding it early makes a difference to how it goes. Day to day the two can feel very similar, so the warning signs that separate them matter more than how bad the symptoms feel. This guide covers how IBS and IBD differ, the symptoms that always need a GP, how doctors tell the two apart, and where an at-home gut test does and does not fit in.
What is the difference between IBS and IBD?
IBS is one of the most common gut conditions in the world. A 2020 pooled analysis of surveys covering more than 400,000 adults found that, depending on the definition used, between roughly 4 and 9 in every 100 people meet the criteria for IBS. The British Society of Gastroenterology's IBS guideline classes it as a disorder of gut-brain interaction. The nerves and muscles of the gut become oversensitive, the signals between gut and brain misfire, and the result is pain, bloating and a changed bowel habit. What IBS does not do is inflame, ulcerate or scar the bowel, and it does not raise your risk of bowel cancer.
IBD is a different kind of illness. In Crohn's disease, inflammation can appear anywhere in the digestive tract and can run through the full thickness of the bowel wall. In ulcerative colitis, it affects the lining of the large intestine. In both, the immune system drives ongoing inflammation that causes ulcers, bleeding and, left untreated, lasting damage, which is why the UK guideline on managing IBD is built around specialist medicines that calm the immune system down. IBD is also much rarer than IBS, though less rare than most people think. A study that traced every case in one Scottish region put the figure at about 1 in every 125 people, one of the highest rates recorded anywhere, and rising year on year.
Why are IBS and IBD so easy to confuse?
On an ordinary day the two can feel identical. Tummy pain, cramping, diarrhoea, urgency, bloating and tiredness appear in both. Both come and go rather than staying constant, and an IBS flare-up can be every bit as disruptive as a flare of inflammation. Because IBS is many times more common, gut symptoms in an otherwise well person are statistically far more likely to be IBS than IBD. Bacterial overgrowth in the small intestine can blur the picture in the same way, and separating SIBO and IBS has complications of its own.
The mix-up has a cost when IBD is the real answer. A 2023 review of 101 studies covering more than 112,000 people found the typical wait from first symptoms to a Crohn's disease diagnosis was around eight months, and around four months for ulcerative colitis. People whose diagnosis took longest were roughly twice as likely to go on to need bowel surgery. That is not a reason to fear ordinary gut symptoms. It is a reason to get the specific warning signs checked promptly instead of managing them at home as IBS.
Which symptoms point to IBD rather than IBS?
The separation rests less on how symptoms feel than on a short list of specific signs. See a GP promptly if you notice any of the following, whatever you think the cause is.
- Blood mixed into your stool. Bleeding from the bowel is not an IBS symptom. Bright red blood, darker blood or black stools all count.
- Losing weight without trying. IBS does not cause weight loss. Ongoing inflammation, and a bowel that absorbs food poorly, can.
- Being woken at night by pain or diarrhoea. IBS tends to quieten during sleep. Symptoms that wake you point away from it.
- Fever during a flare of gut symptoms. A raised temperature suggests inflammation or infection.
- Signs of anaemia. Unusual tiredness, paleness and breathlessness can mean low iron from slow blood loss in the gut, and a routine blood test can confirm it.
- Problems beyond the gut. Persistent mouth ulcers, sore red eyes and painful or swollen joints appear alongside bowel symptoms in some people with IBD.
- A changed bowel habit lasting more than three weeks, particularly if it starts for the first time over the age of 50.
- A close relative with IBD or with bowel or ovarian cancer. These conditions run in families, and a family history lowers the bar for investigation.
One sign on its own does not mean you have IBD. Most people who see blood, for example, turn out to have piles or a small tear rather than anything serious. What each of these signs does mean is that IBS should not be assumed, by you or by anyone selling you something. Each one needs a GP appointment, not a change of diet and not a home test kit.
How do doctors tell IBS and IBD apart?
Usually without a camera, at least at first. The work-up recommended in the UK starts with simple tests a GP can order. Blood tests look for inflammation, anaemia and coeliac disease. A stool sample can be checked for infection. A further stool test, faecal calprotectin, measures a protein that white blood cells release when the bowel is inflamed, which makes it a direct check for the inflammation that defines IBD and is absent in IBS.
Calprotectin does most of the separating work. In a 2023 pooled analysis of 17 studies covering nearly 2,000 patients, the test identified about 86 in every 100 people who had IBD, and came back clear in about 92 in every 100 people whose diagnosis was IBS. An earlier pooled analysis found that when calprotectin and a blood inflammation marker are both normal, the chance of IBD still being present is around 1 in 100. A raised result does not diagnose IBD on its own, because gut infections and some medicines can raise it too. It is the trigger for referral to a gastroenterologist, where a colonoscopy and small tissue samples give the definite answer.
In the UK, calprotectin is an NHS test your GP can arrange, designed for exactly this situation. IBS itself is then diagnosed from the symptom pattern using recognised criteria once those checks are clear. It is a diagnosis in its own right, not a label for leftover symptoms nobody investigated.
Can you have IBS and IBD at the same time?
Yes, and it is common. A 2020 pooled analysis of 27 studies found that among more than 3,000 people whose IBD was in remission, about 1 in 3 reported ongoing symptoms that met the criteria for IBS. Even when remission was confirmed by camera examination rather than symptoms alone, about 1 in 4 did. For those people the answer is not always more inflammation treatment, and the approaches that help IBS, set out in the complete guide to IBS, become relevant alongside IBD care. Anyone with IBD and persistent symptoms should raise them with their IBD team, because active inflammation needs ruling out before IBS is assumed.
The reverse worry, that IBS might turn into IBD over time, has a clearer answer. IBS does not damage the bowel and does not become IBD. When someone diagnosed with IBS is later found to have IBD, the usual explanation is early or missed inflammation that was there from the start. That is one more reason the warning signs above matter more than whichever label you currently have.
Where does an at-home gut microbiome test fit in?
Not in separating these two conditions. No at-home gut microbiome test can diagnose IBS, diagnose IBD, or tell the two apart, and no result from one should ever be read that way. The tests that separate them, calprotectin, blood tests and where needed a colonoscopy, run through your GP, and the stool test among them is free on the NHS. If any of the warning signs above applies to you, see a GP before spending money on anything you can order online.
Where a microbiome test has a place is in the ground left over once those checks are done. Plenty of people are told their blood tests and calprotectin are normal, receive an IBS diagnosis, and still want to understand what is driving their symptoms. An at-home gut microbiome test profiles the variety and balance of bacteria in a stool sample, including the bacterial groups that research has repeatedly found to differ in people with IBS. That is background to bring to conversations with your GP or a dietitian about managing IBS, and it diagnoses nothing. Before deciding whether it would be useful to you, read what gut microbiome testing for IBS can and cannot show.
Researchers are working on stool and blood markers that could one day identify IBS directly rather than by ruling everything else out. A 2025 review describes early candidates, including patterns in gut bacteria and the chemical by-products they leave in stool. It is early research, none of it is in routine clinical use, and no consumer test is validated to do it. For now, the line between IBS and IBD is drawn by NHS tests, not home ones.
When should you be checked?
Book a GP appointment if your gut symptoms are new and have lasted more than a few weeks, if long-standing symptoms have changed character, or if any single item on the list above applies. Blood in your stool, weight loss you did not intend, symptoms that wake you at night, fever, signs of anaemia, a first onset over 50, and IBD or bowel or ovarian cancer in your close family all qualify on their own. Mention a family history explicitly, because it changes which tests a GP arranges and how quickly.
A few situations should not wait for a routine appointment. Heavy or repeated bleeding, severe tummy pain that keeps getting worse, or pain with fever and vomiting need same-day advice from NHS 111, or 999 if you feel dangerously unwell. And if you already have an IBS diagnosis, a genuine change in your symptoms still needs an appointment. The diagnosis was made on the symptoms you had then, not the ones you have now.
This guide is for information only and does not replace medical advice. Speak to your GP or pharmacist about your own symptoms and treatment.
Sources
- Vasant DH, Paine PA, Black CJ, et al. (2021). British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. PubMed | DOI
- Lamb CA, Kennedy NA, Raine T, et al. (2019). British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. PubMed | DOI
- Jones GR, Lyons M, Plevris N, et al. (2019). IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut. PubMed | DOI
- Oka P, Parr H, Barberio B, et al. (2020). Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. PubMed | DOI
- Jayasooriya N, Baillie S, Blackwell J, et al. (2023). Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. PubMed | DOI
- Dajti E, Frazzoni L, Iascone V, et al. (2023). Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics. PubMed | DOI
- Menees SB, Powell C, Kurlander J, Goel A, Chey WD (2015). A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. American Journal of Gastroenterology. PubMed | DOI
- Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC (2020). Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. PubMed | DOI
- Guan M, Chang L (2025). Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterology Clinics of North America. PubMed | DOI
